Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05696444 · ClinicalTrials.gov registry record · NA

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

A NA study of Prostate Cancer and Bladder Cancer, sponsored by Medtronic - MITG.

Active
Registry status
NA
Development phase
144
Enrollment target
6
Study locations

NCT05696444 is a NA study of Prostate Cancer and Bladder Cancer that is active but no longer recruiting, run by Medtronic - MITG. The registered enrollment target is 144 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (76% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05696444, a NA study of Prostate Cancer and Bladder Cancer, is active but no longer recruiting, sponsored by Medtronic - MITG.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
6
Study locations

Study Summary

This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.

Conditions Studied

Prostate Cancer Bladder Cancer End Stage Renal Disease Kidney Cancer Interstitial Cystitis Kidney Injury Congenital Abnormalities Renal Tumor Pelvic Tumor

Interventions

  • DEVICE RAS Prostatectomy
  • DEVICE RAS Cystectomy
  • DEVICE RAS Nephrectomy

Study Locations (6)

California

  • City of Hope - Duarte

Illinois

  • University of Chiago - Chicago

New York

  • Mount Sinai - New York

North Carolina

  • Duke Medical Center - Durham

Ohio

  • Cleveland Clinic - Cleveland

Washington

  • Swedish Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2022-12-14
Est. Completion 2030-01-31
Phase NA

Sponsor

Medtronic - MITG

119 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05696444

The ClinicalTrials.gov registry entry for NCT05696444 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (76% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which RAS Prostatectomy is the first listed.

NCT05696444 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT05696444 about?

NCT05696444 is a clinical study titled "Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)". This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.

What is the current status of trial NCT05696444?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2022-12-14. Estimated completion is 2030-01-31.

What conditions does trial NCT05696444 study?

This clinical trial studies the following conditions: Prostate Cancer, Bladder Cancer, End Stage Renal Disease, Kidney Cancer, Interstitial Cystitis.

What interventions are being tested in trial NCT05696444?

The interventions under investigation include: RAS Prostatectomy (DEVICE), RAS Cystectomy (DEVICE), RAS Nephrectomy (DEVICE).

Who is sponsoring clinical trial NCT05696444?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05696444 being conducted?

This trial has 6 study locations across California, Illinois, New York, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Bladder Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.